Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma

BACKGROUND: Although sorafenib is considered standard therapy for advanced hepatocellular carcinoma (HCC), actual treatments vary. We evaluated the effects of different treatment strategies on overall survival. METHODS: A retrospective study of sorafenib-treated patients with advanced HCC was conduc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Ha, Yeonjung, Lee, Danbi, Shim, Ju Hyun, Lim, Young-Suk, Lee, Han Chu, Chung, Young-Hwa, Lee, Yung Sang, Park, Sook Ryun, Ryu, Min-Hee, Ryoo, Baek-Yeol, Kang, Yoon-Koo, Kim, Kang Mo
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2016
Предметы:
Clinical Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342054/
https://ncbi.nlm.nih.gov/pubmed/27494871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11030
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы